Pulsatile vascular stent graft
A magnetically activated pulsatile stent graft with ferromagnetic materials addresses the limitations of existing stent grafts by providing a flexible and structurally rigid solution for enhancing blood flow and circulation within blood vessels, avoiding skin issues and improving vascular support.
Patent Information
- Application Number
- PCT/US2023/024199
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-06-01
- Publication Date
- 2024-12-05
AI Technical Summary
Current stent graft devices that utilize electrical current for actuation may not be suitable for patients with certain conditions, as they can cause infection and heating of the skin, and existing pulsatile vascular stent grafts may have limitations in effectively facilitating blood flow and structural rigidity within blood vessels.
A magnetically and/or electromagnetically activated pulsatile stent graft that includes a compressible and expandable design with ferromagnetic materials, allowing for diameter changes in response to a magnetic field, providing structural rigidity and flexibility to match blood vessel movements, and facilitating pulsatile blood flow through diameter constriction and expansion.
The solution effectively avoids skin infection and heating, provides structural support within blood vessels, and enhances pulsatile blood flow by allowing the stent graft to expand and constrict in response to a magnetic field, improving blood circulation and maintaining position within the vessel.
Smart Images

Figure US2023024199_05122024_PF_FP_ABST
Abstract
Description
[0001] TITLE
[0002] PULSATILE VASCULAR STENT GRAFT
[0003] TECHNICAL FIELD
[0004] The application relates generally to medical devices, and more particularly to a magnetically and / or electromagnetically-activated circulatory assist device configured to be placed within a blood vessel (artery or vein) and related methods. More particularly, the application discloses intravascular circulatory assist devices that include a pulsating stent graft that includes at least one portion that is configured to change shape in response to an applied magnetic field, and related methods of using the circulatory assist devices.
[0005] BACKGROUND
[0006] Some current stent graft devices utilize electrical current for actuation, such as that described in Palma et al. “Pulsatile stent graft: a new alternative in chronic ventricular assistance,” Revista Brasileira de Cirurgia Cardiovascular (2013), 28(2):217; dx.doi.org / 10.5935 / 1678-9741.20130031, which may not be desirable for patients with certain circumstances.
[0007] US Patent Application Publication 2022 / 0117719 Al to Leonhardt (April 21, 2022) for “Pulsatile Vascular Stent Graft” describes an intravascular device that includes a stent structure and at least one annular band that is configured to be electronically activated. In some embodiments, the annular band may be an electro-activated polymer, such as a ferroelectric polymer or a dielectric polymer. Accordingly, an electrical (or, e.g., magnetic) field may be applied to the annular band and the annular band will change shape (e.g., expand and / or contract) in response to the applied electric field such as a voltage.
[0008] DISCLOSURE
[0009] Described herein is a vascular device that avoids infection and heating of the subject’s skin by utilizing an electromagnetically and / or magnetically activated stent graft. Embodiments herein may be used to facilitate blood flow within the subject’s blood vessel(s).
[0010] In certain embodiments, the circulatory assist device includes a stent graft that is compressible and expandable. In some embodiments, at least a portion of stent graft is biased to expand such that exterior walls of the stent graft contact the interior walls of the subject’s blood vessel when the circulatory device is positioned within the subject’s blood vessel and in a relaxed state. In additional embodiments, an actuatable portion of stent graft may be biased to constrict in a relaxed state such the actuatable portion of the stent graft expands the diameter of the actuatable portion (e.g. , to match the diameter of the subject’s blood vessel) in the actuated state. The stent graft may include one or more reinforcing members arranged in a pattern (e.g., a reticulated pattern), which provides structural rigidity so the circulatory assist device can be maintained in the desired position within the subject’s blood vessels. In addition, the stent graft may exhibit flexibility such that the circulatory assist device flexes with pulsatile movement of the subject’s blood vessel wall. The circulatory assist device can function in and / or transition between a relaxed state, a partially actuated state, and a fully actuated state.
[0011] In certain embodiments, the circulatory assist device utilizes one or more electromagnets positioned just above the subject’s skm adjacent the device that generate a magnetic field via transcutaneous transmission to partially actuate and / or fully actuate one or more actuatable portion(s) of the stent graft. In other words, the magnetic field transfers through the subject’s skin, tissue, and blood vessel(s) to a stent graft within the subject’s blood vessel. In response to the applied magnetic field, one or more actuatable portions of a stent graft within the subject’s blood vessel may change in diameter (e.g., constrict or expand).
[0012] In additional embodiments, the circulatory includes a stent graft that comprises an inner member and an outer member. The inner member of the stent graft includes one or more actuatable portions that may change in diameter (e.g., constrict or expand). The actuatable portions of the inner member are configured to actuate in response to an applied magnetic field. The magnetic field may be generated, for example, via internal electromagnets and electronics within the portion of the circulatory assist device that is configured to be deployed and / or remain within the subject’s blood vessel(s).
[0013] Diametric movements (e.g, constriction and / or expansion) of the actuatable portion(s) of the stent graft contribute to pulsating blood flow within the blood vessel. In addition, constriction and / or expansion of the actuatable portion(s) of the stent graft may be coordinated with the pulsating blood flow occurring in the vessel.
[0014] To change the diameter of the actuatable portion(s) of the stent graft, the actuatable portion(s) of the stent graft may include ferromagnetic material that is sensitive to an applied magnetic field. The application of the magnetic field (e.g., from one or more electromagnets) to the ferromagnetic material may repel or attract the ferromagnetic material. For example, the ferromagnetic material may include one or more magnetic elements and / or ferromagnetic nanoparticles distributed throughout the actuatable portion(s) of the stent graft. In operation, the magnetic field attracting the ferromagnetic material of the stent graft may expand the actuatable portion(s) of the stent graft, and the magnetic field repelling the ferromagnetic material of the stent graft may constrict the actuatable portion(s) of the stent graft.
[0015] The magnetic field may be applied to the circulatory assist device in various ways. For example, in some embodiments, the magnetic field may be applied by a single electromagnet external to and relatively adjacent the subject. In embodiments with a single electromagnet, the magnetic field may be modulated and / or concentrated (e.g., focused, localized) in a plane and / or at one of the actuatable portions of the stent graft. In addition, a concentrated magnetic field may be steered as desired, such as through the use of a controller that directs the magnetic field.
[0016] In additional embodiments, the magnetic field may be applied by multiple selectively actuatable external electromagnets. The electromagnets may be arranged in series so that the electromagnets can be activated then deactivated in succession to change the diameter of (e.g., constrict or expand) portions of the stent graft.
[0017] In further embodiments, the magnetic field may be applied by one or more internal electromagnets that are positioned within the stent graft that is positioned within the subject’s blood vessel(s). For example, the circulatory assist device may generate an electrical current within the stent graft that activates internal electromagnets to generate an internal magnetic field.
[0018] In some embodiments, a circulatory assist device includes a stent graft with multiple independent portions arranged in series along a length of the stent graft. In additional embodiments, the circulatory assist device includes a stent graft with multiple independent portions arranged in parallel (e.g, laterally) around the circumference of the stent graft such that each portion extends the full length of the stent graft. For example, the stent graft may include alternating sections of independently actuatable portions and non-actuatable portions of the stent graft. The independently actuatable portions or sections of actuatable portions of the stent graft are each individually configured to change diameter (e.g, constrict or expand) in response to an applied magnetic field. For example, each actuatable portion or section of each actuatable portion of the stent graft may be independently actuated by a concentrated (e.g, focused, localized) magnetic field applied to the respective actuatable portion, which may change the diameter (e.g, constrict or expand) the respective actuatable portion of the stent graft. In some embodiments, each actuatable portion or each section of each actuatable portion of the stent graft may be successively actuated (e.g., by a moving magnetic field) such that the diameter of the stent graft successively changes (e.g. , constricts or expands) along the length of the stent graft.
[0019] Thus described, among other things, is a pulsating stent graft that includes a stent graft, a stent graft and a band. The stent graft of the stent graft is biased to expand radially outward such that at least a portion of an exterior surface of the stent graft is configured to contact an interior wall of a blood vessel of a subject so as to be retained in the blood vessel. The band of the stent graft comprises a ferromagnetic material and is configured to change diameter in response to an applied magnetic field.
[0020] In some embodiments, a circulatory assist device may include additional components beyond the stent graft. For example, the circulatory assist device may include one or more electromagnets that may remain external to the subject, and that generate a magnetic field to change the diameter of the actuatable portion(s) of the stent graft.
[0021] Furthermore, the circulatory assist device may include a controller and / or a power source in electronic communication with the electromagnet(s). The controller may be configured to modulate the magnetic field of the electromagnet and / or may even be configured to steer the magnetic field generated by the electromagnet. In embodiments that include multiple electromagnets, the controller may be configured to selectively activate and deactivate each electromagnet to move the location of the magnetic field.
[0022] In further embodiments of the disclosure, a method of facilitating pulsatile blood flow includes positioning a circulatory assist device within a blood vessel of a subject. The circulatory assist device includes a sent graft comprising a portion including ferromagnetic material. The portion of the stent graft may be configured to change diameter in response to a magnetic field. The method additionally includes applying the magnetic field to the portion of the stent graft to change the diameter of the portion of the stent graft.
[0023] BRIEF DESCRIPTION OF THE DRAWINGS
[0024] FIG. 1 is a side elevation view of a circulatory assist device in accordance with embodiments of this disclosure;
[0025] FIG. 2 is a partial cross-sectional view of a catheter being used to insert the circulatory assist device of FIG. 1 into a blood vessel of a subject; FIG. 3 is a partial cross-sectional view of the circulatory assist device of FIG. 1 positioned within a blood vessel of a subject (e.g, a mammalian patient) and in a first arrangement;
[0026] FIG. 4 is a partial cross-sectional view of the circulatory assist device of FIG. 3 positioned within the blood vessel in a second arrangement;
[0027] FIG. 5 is a front perspective view of a portion of an intravascular device in a first arrangement in accordance with embodiments of this disclosure;
[0028] FIG. 6 is a front perspective view of the portion of the intravascular device of FIG. 6 in a second arrangement in accordance with embodiments of this disclosure;
[0029] FIG. 7 is a front perspective view of an embodiment of an actuatable section of an intravascular device in a first arrangement in accordance with embodiments of this disclosure;
[0030] FIG. 8 is a front perspective view of the actuatable section of the intravascular device of FIG. 7 in a second arrangement in accordance with embodiments of this disclosure;
[0031] FIG. 9 is a cross-sectional view of the actuatable portion of the intravascular device of FIGS. 7 and 8 taken along the 9-9 section line of FIG. 8;
[0032] FIG. 10 is a schematic illustration of an embodiment of the circulatory assist device of FIG. 1 including electrical components configured to interact with the circulatory assist device;
[0033] FIG. 11 is a perspective view of an embodiment of the circulatory assist device of FIG. 1 including an outer member in accordance with embodiments of this disclosure;
[0034] FIG. 12 is a perspective view of the circulatory assist device of FIG. 11 with the outer member removed illustrating an inner member thereof;
[0035] FIG. 13 shows the inner member of the circulatory assist device of FIG. 12 in a first arrangement;
[0036] FIG. 14 shows the inner member of FIG. 13 in a second arrangement;
[0037] FIG. 15 shows a simplified longitudinal cross-sectional view of the inner member of the circulatory assist device of FIG. 12;
[0038] FIG. 16 shows a simplified axial cross-sectional view of the inner member of the circulatory assist device of FIG. 12;
[0039] FIG. 17 shows an exploded view of the circulatory assist device of FIGS. 11 and 12;
[0040] FIG. 18 shows a side view of the inner member of the circulatory assist device of FIG. 17 in a partially assembled state;
[0041] FIG. 19 shows an end view of the inner member of FIG. 18; FIG. 20 shows a cross-section of the inner member of the circulatory assist device of FIG. 17;
[0042] FIG. 21 shows a perspective view of a central support member of the inner member of the circulatory assist device of FIG. 17;
[0043] FIGS. 22 and 23 show an embodiment of the ferromagnetic material isolated from the band of the intravascular device when no magnetic field is applied (FIG. 22), and when a magnetic field is applied (FIG. 23) illustrating a deflection thereof;
[0044] FIG. 24 is a table showing deflection distances of the ferromagnetic material of the band of the intravascular device resulting from different conditions of the internal electromagnets positioned within the inner member of FIGS. 18 and 19;
[0045] FIG. 25 is a table illustrating magnetic force calculations resulting from manipulating additional variables of the internal electromagnets of the inner member of FIGS. 18 and 19;
[0046] FIG. 26 is a graph illustrating a relationship between magnetomotive force and wire gauge for the internal electromagnets of the inner member of FIGS. 18 and 19;
[0047] FIG. 27 is is a graph illustrating a relationship between potential power and wire gauge for the internal electromagnets of the inner member of FIGS. 18 and 19;
[0048] FIG. 28 is a chart illustrating the magnetic field (e g., the magnetic flux density) within the inner member of FIGS. 18 and 19 in the assembled state with the internal electromagnets activated;
[0049] FIG. 29 illustrates results from a finite element analysis of simulated blood flow through the inner member of FIGS. 18 and 19 in the expanded state;
[0050] FIG. 30 illustrates results from a non-linear analysis of simulated blood flow through the inner member of FIGS. 18 and 19 in the constricted state;
[0051] FIG. 31 shows a schematic view of the electrical components of the circulatory assist device of FIGS. 11 and 12;
[0052] FIG. 32 is a flowchart of an illustrative method of facilitating pulsatile blood flow within a subject’s blood vessel(s);
[0053] FIG. 33 is a schematic view' of a circulatory assist system including the circulatory assist device of FIGS. 11 and 12 and external electrical components configured to interact with the circulatory assist device of FIGS. 1 1 and 12; and
[0054] FIG. 34 illustrates an embodiment of fin design with cuff simulation (cuff with metal particles). MODE(S) FOR CARRYING OUT THE INVENTION In embodiments of the disclosure, the circulatory assist device includes an intravascular device (also referred to as a pulsating stent graft or an electrically activated pulsating vascular stent graft) that includes a stent graft and one or more bands that are actuatable (e.g, magnetically actuatable bands). The intravascular device is configured to be placed within the blood vessel (s) of a subject (e.g., a mammal, such as a human). For example, the intravascular device may be placed in the descending thoracic aorta above (e.g, upstream of) the subject’s kidneys, in the descending aorta below (e.g, downstream of) the subject’s kidneys, or in the ascending thoracic aorta above the origin of coronary arteries and below the Innominate artery. In addition, the intravascular device may be placed in any other peripheral artery, or any peripheral vein, or inferior or superior vena cava. Furthermore, the intravascular device may be positioned w ithin a hemodialysis graft or another stent graft. The circulatory assist device also includes one or more electromagnets outside of the subject positioned (e.g., by a belt wrapped about the patient’s body) on the outside of the skin immediately above and very close to the implanted intravascular device and the bands of the intravascular device. The one or more electromagnets thus may be used to wirelessly actuate the bands of the intravascular device, which causes the bands to expand and / or constrict to facilitate pulsatile blood flow within the subject. Therefore, the application of a magnetic field external to the subject can be used to control pulsations of the intravascular device.
[0055] FIG. 1 is a side elevation view of a circulatory assist device 100 in accordance with embodiments of this disclosure. The circulatory' assist device 100 includes an intravascular device 102 including a stent graft 104 and a band 106 (e.g., a selectively actuatable band) configured to be selectively actuated by application of a magnetic field 108. The circulatory' assist device 100 may include any embodiment of the intravascular device 102 disclosed herein. Although shown as only a single section of the band 106, in some figures hereof, as shown and described in FIGS. 5-6, the intravascular device 102 may include multiple integrated sections of the stent graft 104, each with a band 106.
[0056] The intravascular device 102 is sized and configured for insertion into a blood vessel of a subject (e.g., the human aorta). The intravascular device 102 is configured with sufficient flexibility' and to facilitate introduction and removal into the subject’s blood vessels and sufficient rigidity to brace against the interior walls of the subject’s blood vessel(s) to inhibit (e.g., prevent) the intravascular device 102 from migrating along the subject’s blood vessel. The band 106 includes an annular or semi-annular shape (e.g., a right circular cylinder shape or a hyperboloid shape where the shape is that of a hyperbola revolved about its conjugate axis). In certain embodiments of the disclosure, the band 106 includes non- polymeric ferromagnetic material (i.e., not a ferroelectric polymer or dielectric polymer).
[0057] In some embodiments, an end of a segment of the stent graft 104 is connected to an end of the band 106 such that the stent graft 104 and the band 106 share a common central longitudinal axis 110 of the intravascular device 102. In certain embodiments, the intravascular device 102 includes alternating segments of the stent graft 104 and the band 106 arranged in series along a longitudinal length (e.g., an axial length) of the intravascular device 102. In additional embodiments, the stent graft 104 extends along the entire longitudinal length of the intravascular device 102, and the band 106 partially or wholly encompasses a section of the stent graft 104. In addition, the band 106 may comprise two or more separate components combined to at least partially encompass the stent graft 104.
[0058] The longitudinal length of the intravascular device 102 may be configured based in part on where the intravascular device 102 will be inserted within the subject during use (e.g., the specific blood vessel the intravascular device 102 will be positioned within during use). As non-limiting examples, the intravascular device 102 may have a longitudinal length within a range of from about 2 centimeters (cm) to about 20 cm, such as from about 4 cm to about 15 cm, or from about 5 cm to about 10 cm (e.g., about 8 cm).
[0059] As shown in FIG. 1, in various embodiments, the stent graft 104 includes a flexible material 112 and a reinforcing structure 114. The reinforcing structure is configured with sufficient rigidity to brace against the interior walls of the subject’s blood vessel and to expand radially outward while not being compressed by the band 106. The reinforcing structure is also configured with sufficient flexibility to be compressed by the band 106 while the band 106 is in a compressed state. For example, the reinforcing structure 114 may function similar to a spring that stores energy when a force (e.g. , a compressive force) is applied to constrict the stent graft 104, and then the stent graft 104 expands when the force is no longer applied thereto. In the expanded state, the stent graft 104 may have an outer diameter within a range of from about 10 millimeters (mm) to about 26 mm, such as from about 15 mm to about 24 mm, from about 18 mm to about 22 mm (e g., about 20 mm or about 22 mm).
[0060] The reinforcing structure 114 may be a mesh, w eave, braid, etc., or a pattern of wirelike elements that are arranged to form the reinforcing structure 114. In some embodiments, the reinforcing structure 114 may include nitinol wires arranged with alternating bends to form a zigzag or other shape extending circumferentially around the intravascular device 102, and in particular the flexible material 112. In addition, the reinforcing structure 114 may be made of any suitable biocompatible material, such as a polymer, metal, etc. In some embodiments, the reinforcing structure 114 may be coated with another material, such as, for example a biocompatible polymer like expanded polytetrafluoroethylene (PTFE), also known as ePTFE that is commercially available from W. L. Gore & Associates at 551 Paper Mill Rd., Newark, NJ, US.
[0061] The flexible material 1 12 may serve as an artificial blood vessel wall. The flexible material 112 may be made of any suitable biocompatible material, such as a biocompatible polymer. As a specific, non-limiting example, the flexible material 112 may comprise ePTFE. In certain embodiments, the stent graft 104 is a GORE® stent graft with one or more portions of the stent graft 104 replaced with a nanoferromagnetic material to form the band(s) 106. In certain embodiments, the stent graft 104 further includes a metallic mesh covered by ePTFE.
[0062] In various embodiments, the band 106 (e.g., the one or more actuatable portion(s)) of the intravascular device 102 includes a ferromagnetic material that may be positioned on or within an additional flexible material 116 (e.g., similar to the flexible material 112). For example, the band 106 may comprise ferromagnetic elements (e.g., wires, fibers, particles, etc.) on or within a flexible biocompatible polymer material, such as ePTFE. In some embodiments, the band 106 includes a combination of nanofibers of a flexible biocompatible polymer material, such as ePTFE, and nanofibers of a ferromagnetic material. For example, the nanofibers of the flexible biocompatible polymer may be intermeshed, interwoven, or braided together to form the band 106. The ferromagnetic material of the band 106 may include one or more ferromagnetic materials, such as neodymium compounds (Nd2Fei4B), samarium compounds (SmCos), Sm(Co, Fe, Cu, Zr)?, alnico alloys (e.g., alloys of Al-Ni-Co), and / or ferrite (FezOs). Accordingly, when the magnetic field 108 is applied to the band 106, the magnetic field 108 will repel and / or attract the ferromagnetic elements within the band 106 to change the shape of (e.g., expand and / or constrict) the band 106 of the intravascular device 102.
[0063] The intravascular device 102 also includes one or more electromagnets 118. The one or more electromagnets 118 are configured to produce a magnetic field 108. The one or more electromagnets 118 are arranged outside ofthe subject’s body to apply the magnetic field 108 to the band 106. The one or more electromagnets 118 may be configured to generate a magnetic field having a magnitude within a range of from about 1 milliTesla (mT) to about 10 Tesla, such as about 0.001 T, about 0.01 T, about 0.1 T, about 1 T, about 1.5 T, about 2 T, about 2.5 T, about 3 T, about 3.5 T, about 4 T, about 4.5 T, about 5 T, about 5.5 T, about 6 T, about 6.5 T, about 7 T, about 7.5 T, about 8 T, about 8.5 T, about 9 T, about 9.5 T, and / or about 10 T. Because the magnitude of the magnetic field may be relatively high, the electromagnet(s) may be activated and deactivated so as not to cause issues w ith blood circulation that may occur by extended application of magnetic fields, which are described in Stephanie Wiesemann et al., “Impact of sequence type and field strength (1.5, 3, and 7T) on 4D flow MRI hemodynamic aortic parameters in healthy volunteers,” Magnetic Resonance inMedicine (Feb. 2021) Vo. 85, 721-733, doi: 10.1002 / mrm.28450. Epub 2020 Aug 4.
[0064] In some embodiments, the one or more electromagnets 118 include one or more large air core electromagnets configured to be placed external to the subject. The one or more electromagnet 118 may be connected to a specialized circuit utilizing two or more electrodes and two or more leads to reduce unwanted quadrature signal(s). The one or more electromagnet 118 may be circular and / or square coils with anywhere from about 10 turns to about 1000 turns of wire, such as about 100 turns, about 200 turns, about 300 turns, about 400 turns, about 500 turns, about 600 turns, about 700 turns, about 800 turns, about 900 turns, or about 1000 turns. The coils may be made of copper wire or other conductive metal wire with a diameter within a range of from about 0.0799 mm (e.g, 40 American Wire Gauge (AWG)) to about 2.588 mm (about 10 AWG), such as, for example about 0.812 mm diameter (about 20 AWG) or about 0.255 mm (about 30 AWG). The winding space of the coil may be from about 1-cm to about 10-cm wide (e g., 5 cm wide) and the inner diameter of the windings may be within a range of from about 5 cm to about 50 cm, such as about 5 cm, about 10 cm, about 15 cm, about 20 cm, about 25 cm, about 30 cm, about 35 cm, about 40 cm, about 45 cm, or about 50 cm. The external electromagnet(s) 118 may be capable of producing a greater magnetic field than that described in Leonhardt. For example, the electromagnet(s) may be similar to those utilized in Alexander Kolin, “A New Approach to Electromagnetic Blood Flow Determining by Means of Catheter in an External Magnetic Field,” National Academy of Sciences Vol. 65, No. 3, pp. 521-527 (Mar. 1970) doi: 10.1073 / pnas.65.3.521.
[0065] The magnetic field 108 may be focused (e.g. , concentrated) at a plane perpendicular to the longitudinal length (e g., the axial length) of the band 106 of the intravascular device 102. The magnetic field may be focused and steered in a similar manner to that described in Cubero et al. “Exploring the limits of magnetic field focusing: Simple planar geometries,” Results in Physics vol. 19 (Dec. 2020), doi.org / 10.1016 / j.rinp.2020.103562 describes focusing magnetic fields. For example, the magnetic field 108 may be focused at a plane perpendicular to an axial length of the intravascular device 102. In addition, the focused magnetic field may be steered along the axial length of the band 106 to successively (e.g., sequentially, or progressively) actuate each segment of the band 106 along the axial length of the band 106 from the distal end to the proximal end. Thus, a single section of the band 106 may provide directional blood flow within the subject’s blood vessel(s). The same concept may be applied to multiple sections of the intravascular device 102, where each section includes a band 106. Tn some embodiments, the ends of the intravascular device 102 may remain in an expanded state during actuation of the section(s) of the band 106 so as to prevent blood from accumulating and / or stagnating near the walls of the blood vessel(s).
[0066] In some embodiments, the magnetic field 108 may be applied by utilizing multiple external electromagnets 118 arranged in series external to the subject. The multiple external electromagnets 118 may be activated and / or deactivated in series to successively actuate (e.g., expand or contract) segments and / or sections of the band 106 of the intravascular device 102.
[0067] FIG. 2 is a partial cross-sectional view of a catheter 122 being used to insert the circulatory assist device 100 of FIG. 1 into a blood vessel 120 of a subject. Pnor to insertion of the catheter 122 into a subject, the circulatory assist device 100 may be compressed and inserted into the catheter 122. The reinforcing structure 114 of the stent graft 104 is configured with sufficient flexibility for the radial compression of the stent graft 104 to be compressed and inserted into the catheter 122. The flexible material 112 of the stent graft 104 and the additional flexible material 116 of the band 106 of the intravascular device 102 are configured to sufficiently deform for positioning within the catheter 122. The guide wire 124 may also be positioned within the catheter 122 to extend through the circulatory assist device 100.
[0068] As show n in FIG. 2, the circulatory assist device 100 may be positioned in a location in the blood vessel 120 with a buildup of plaque 126. In addition to facilitating pulsatile blood flow, expansion and constriction of the band 106 of the intravascular device 102 may be utilized to compress and / or break up the plaque 126 that has accumulated within the subject’s blood vessel 120 to further improve flow through the respective blood vessel 120.
[0069] The blood vessel 120 may be the descending thoracic aorta above (e.g. upstream of) the subject’s renal arteries, the descending aorta below (e g., downstream of) the subject’s renal arteries, the ascending thoracic aorta above the origin of coronary arteries and below the Innominate artery, or any other peripheral artery, any peripheral vein, or inferior or superior vena cava. In addition, the intravascular device 102 may be positioned within a hemodialysis graft or another stent graft.
[0070] The stent graft 104 of the intravascular device 102 is configured to expand to contact the wall of the blood vessel 120 after being inserted into the blood vessel 120 and removed from the catheter 122. For example, as previously discussed the stent graft 104 of the intravascular device 102 may be biased to expand radially outward. In particular, the reinforcing structure 114 of the stent graft 104 is sufficiently rigid to expand, upon removal from the catheter 122 within the blood vessel 120, to expand and cause the stent graft to contact the wall of the blood vessel 120.
[0071] After insertion into the subject, the tip of the catheter 122 may be guided to the desired location within the blood vessel 120 with the assistance of the guide wire 124. The circulatory assist device 100 (e.g., the intravascular device 102) may then be deployed out of the tip of the catheter 122. As the stent graft 104 of the intravascular device 102 exits the catheter 122, the reinforcing structure 114 of the stent graft 104 at the distal end of the intravascular device 102 may rebound like a spring and expand to cause a first end of the intravascular device 102 to contact the wall of the blood vessel 120. Additionally, the band 106 of the intravascular device 102 (and, optionally, the stent graft 104 therein) may expand as the band 106 is deployed from the catheter 122. As the proximal end of the intravascular device 102 exits the catheter 122, the reinforcing structure 114 of the stent graft 104 at the proximal end of the intravascular device 102 may rebound like a spring and expand to cause a second end of the intravascular device 102 to contact the wall of the blood vessel 120 (shown in FIG. 3). After the circulatory assist device 100 has been deployed to the desired location within the blood vessel 120, the catheter 122 and the guide wire 124 may then be withdrawn from the patient.
[0072] After the circulatory assist device 100 has been deployed to the desired location within the blood vessel 120, the band 106 may be actuated to alternate between a first arrangement (non-actuated state) and a second arrangement (actuated state).
[0073] FIG. 3 is a partial cross-sectional view of the circulatory assist device 100 of FIG. 1 positioned within a blood vessel 120 of a subject (e.g., a mammalian patient) and in a first arrangement. FIG. 4 is a partial cross-sectional view of the circulatory assist device 100 of FIG. 3 positioned within the blood vessel 120 in a second arrangement. As shown in FIGS. 3-4, the band 106 of the intravascular device 102 is configured to actuate between a constricted state (FIG. 4) and an expanded state (FIG. 3). In some embodiments, the band 106 is in the expanded state in the first arrangement and is in the constricted state in the second arrangement. However, in other embodiments, the band 106 is in the constricted state in the first arrangement and is in the expanded state in the second arrangement (FIGS. 7 and 8). The band 106 is configured to actuate from the first arrangement to the second arrangement in response to application of the magnetic field 108 thereto, and the band 106 is configured to actuate from the second arrangement to the first arrangement in response to removal of (e.g. , reducing the magnitude of or eliminating) the magnetic field 108 therefrom. In some embodiments, the band 106 is configured to constrict from the expanded state (first arrangement) to the constricted state (second arrangement) in response to application of the magnetic field 108 and to expand from the constricted state (second arrangement) to the expanded state (first arrangement) in response to removal of the magnetic field 108. In other embodiments, the band 106 is configured to expand from the constricted state (first arrangement) to the expanded state (second arrangement) in response to application of the magnetic field 108 and to constrict from the expanded state (second arrangement) to the constricted state (first arrangement) in response to removal of the magnetic field 108. Actuation of the band 106 of the intravascular device 102 may facilitate pulsatile blood flow within the blood vessel 120 and / or compress and / or break up the plaque 126.
[0074] The stent graft 104 of the intravascular device 102 may be biased to expand such that the stent graft 104 provides a radial force to firmly secure the intravascular device 102 within the blood vessel 120, while still being sufficiently flexible to enable vessel wall pulsatility. In addition, the radial force applied by the stent graft 104 of the intravascular device 102 may not be so strong as to prevent the actuation and shape change of the band 106 when a magnetic field is applied.
[0075] In some embodiments, the band 106 of the intravascular device 102 is actuated and controlled by a device positioned outside of the patient's body that is in proximity of the band 106 of the implanted intravascular device 102. The external device may be one or more electromagnets 118 that may be held in place with an external belt wrapped around the subj ecf s thorax. The one or more electromagnets 118 may be connected to a power source and, optionally, a controller that may be used to control the timing of the magnetic field that actuates the band 106 of the intravascular device 102. The one or more electromagnets 118 may be configured to generate the magnetic field 108 in a single direction when current flows through the one or more electromagnets 118. The magnetic field 108 can then be focused, for example in a plane, which can then be steered (e.g, directed) in a single direction. In certain embodiments, the intravascular device actuates in coordination with the patient's heartbeat. In certain embodiments, the intravascular device actuates at a set rate (e.g., 60 to 120 bpm).
[0076] FIG. 5 is a front perspective view of a portion of an intravascular device 102 in a first arrangement in accordance with embodiments of this disclosure. FIG. 6 is a front perspective view of the portion of the intravascular device 102 of FIG. 6 in a second arrangement in accordance with embodiments of this disclosure. As shown in FIGS. 5 and 6, in some embodiments, the intravascular device 102 includes alternating sections of the stent graft 104 and the band 106 along an axial length of the intravascular device 102. For example, the intravascular device 102 includes a first section with a band 106, a second section with a band 106, and a third section with a band 106. In some embodiments, each band 106 may at least partially encompass (e.g., surround) the stent graft 104 that extends continuously through each respective band 106. In additional embodiments, ends of each band 106 may be secured to ends of individual sections of the stent graft 104.
[0077] The stent graft 104 of the intravascular device 102 typically comprises a flexible material 112 and a reinforcing structure 114 that provides rigidity to the intravascular device 102. In addition, the stent graft 104 may be biased to expand radially outward. For example, the reinforcing structure 114 may function like a spring that stores energy when a force (e.g., a compressive force) is applied to constrict the stent graft 104, and then the stent graft 104 expands when the force is no longer applied to constrict the stent graft 104.
[0078] The reinforcing structure 114 may include wires arranged with alternating bends to form a zigzag or other shape extending circumferentially around the intravascular device 102. The wires of the reinforcing structure 114 may be made of any suitable biocompatible material, such as a polymer, metal, etc. For example, the reinforcing structure 114 may include nitinol wires.
[0079] The flexible material 112 may serve as an artificial blood vessel wall. The flexible material 112 may be made of any suitable biocompatible material, such as a biocompatible polymer. As a specific, non-limiting example, the flexible material 112 may comprise ePTFE.
[0080] In the embodiments of FIGS. 5 and 6, the band 106 of the intravascular device 102 may include a ferromagnetic material positioned on or within an additional flexible material 116 (e.g., similar to the flexible material 112). For example, the band 106 may include ferromagnetic elements positioned on or within a flexible biocompatible polymer material, such as ePTFE. The ferromagnetic material of the band 106 may include one or more ferromagnetic materials, such as neodymium compounds (Nd2Fei4B), samarium compounds (SmCos), Sm(Co, Fe, Cu, Zr)?, alnico alloys e.g., alloys of Al-Ni-Co), and / or ferrite (Fe2C>3). Accordingly, when the magnetic field 108 is applied to the band 106, the magnetic field 108 will repel and / or attract the ferromagnetic elements within the band 106 of the intravascular device 102 to change the shape of (e.g, expand and / or constrict) the band 106 of the intravascular device 102.
[0081] Each section of the intravascular device 102 is preferably independently actuated. In some embodiments, each band 106 is independently actuatable. For example, each band 106 may be successively (e.g. , sequentially) actuated to facilitate directional blood flow w ithin the subject’s blood vessel(s). Sequential actuation of each band 106 and the corresponding section of the intravascular device may be achieved in several ways. In some embodiments, the ends of the intravascular device 102 may remain in an expanded state during actuation of the section(s) of the intravascular device 102 so as to prevent blood from accumulating and / or stagnating near the walls of the blood vessel(s).
[0082] In additional embodiments, each section of the intravascular device 102 and its respective band 106 may be associated with a respective electromagnet 118 (FIG. 8) configured to actuate the respective band 106. For example, the electromagnet 118 proximate a distal end of the intravascular device 102 may be actuated, then the electromagnet 118 proximate the center of the intravascular device 102 may be actuated, and finally the electromagnet 118 proximate a proximal end of the intravascular device 102 may be actuated. In embodiments that include multiple electromagnets 118. The multiple electromagnets 118 may be arranged in series within an external belt on the subject’s thorax.
[0083] In some embodiments, axial ends of the band 106 may be connected to axial ends of sections of the stent graft 104. In additional embodiments, the band 106 includes a semiannular or annular shape that partially or fully encompasses the stent graft 104 of the intravascular device 102. In addition, the band 106 may include two or more separate components combined together to at least partially encompass the stent graft 104 of the intravascular device 102.
[0084] In addition, while in the constricted state, the center of the band 106 may have a narrower diameter than ends proximate the stent graft 104. When the band 106 is in the expanded state, the diameter of band 106 may expand to the diameter of the blood vessel 120 (FIGS. 2-4) and / or the diameter of the stent graft 104. The band 106 of the intravascular device 102 may accommodate expansion and / or contraction in several ways. In some embodiments, when the band 106 is in the constricted state, ends of the band 106 and / or the stent graft 104 may also be constricted inward in a same or similar amount as an axial middle of the band 106 resulting in a right circular cylindrical shape, while in other embodiments, ends of the band 106 and / or the stent graft 104 may be constricted less than that of the axial middle of the band 106 resulting in an hourglass shape (e.g., a hyperboloid shape where a hyperbola is revolved about its conjugate axis).
[0085] The band 106 of the intravascular device 102 includes ferromagnetic material on or within the additional flexible material 116, such as a flexible biocompatible polymer (e.g., ePTFE).
[0086] When the magnetic field 108 is applied to the ferromagnetic elements 128 of the band 106, the ferromagnetic elements 128 are activated by the external electromagnet 118, which causes the band 106 to actuate and expand radially outward as shown in FIG. 8 (or constrict radially inward as shown in FIG. 4). Similarly, when the magnetic field 108 is reduced or removed, the ferromagnetic elements 128 and remainder of the band 106 constrict radially inward and return to the constricted state (e.g., the constricted state) as shown in FIG. 7 (or expand radially outward as shown in FIG. 3).
[0087] In some embodiments, applying the magnetic field 108 via the external electromagnet 118 to the ferromagnetic elements 128 of the band 106 actuates (e.g., expands) substantially the entire band 106. For example, the magnetic field 108 may be applied across the entire band 106 of the intravascular device 102. In additional embodiments, applying the magnetic field 108 via the external electromagnet 118 to the ferromagnetic elements 128 of the band 106 actuates (e.g., expands) only a small segment of the band 106. For example, as previously discussed, the magnetic field 108 may be focused (e.g, concentrated) at a plane perpendicular to the longitudinal length (e.g., the axial length) of the band 106 of the intravascular device 102. In addition, the focused magnetic field may be steered to successively (e.g., sequentially, or progressively) actuate each segment of the band 106 along the axial length of the band 106 from the distal end to the proximal end. Thus, a single section of the band 106 may provide directional blood flow within the subject’s blood vessel(s). In further embodiments, applying the magnetic field 108 includes utilizing multiple electromagnets 118 arranged in series external to the subject. The multiple electromagnets 118 may be activated and / or deactivated in series to successively actuate (e.g., expand) successive bands 106 along the intravascular device 102. In some embodiments, the ends of the intravascular device 102 may remain in an expanded state during actuation of the section(s) of the intravascular device 102 so as to prevent blood from accumulating and / or stagnating near the walls of the blood vessel(s).
[0088] In some embodiments, the ferromagnetic elements 128 are polarized to align in a predetermined orientation. When forming the intravascular device 102 the band 106 of the intravascular device 102 may be subjected to a radial magnetic field to polarize the ferromagnetic elements 128 in the predetermined orientation. For example, the predetermined orientation of the ferromagnetic elements 128 may include a first pole (e.g., North Pole) on a radially outermost portion of the ferromagnetic elements 128, and a second pole (e.g., South Pole) on a radially innermost portion of the ferromagnetic elements 128. Thus, application of the magnetic field 108 to the band 106 may radially attract or repel the ferromagnetic elements 128 of the band 106 of the intravascular device 102, resulting in constriction or expansion of the band 106 based at least in part on the predetermined orientation.
[0089] Responsive to the magnetic field 108 being applied to the aligned ferromagnetic elements 128 of the band 106, the ferromagnetic elements 128 are attracted to the one or more electromagnets 118, which causes the band 106 to actuate from the first arrangement to the second arrangement. In some embodiments, the predetermined orientation of the ferromagnetic elements 128 on a side closest to the one or more electromagnets 118 are arranged in a first orientation and the ferromagnetic elements 128 on an opposing side opposite the one or more electromagnets 118 are oriented in a second direction, opposite the first direction. Similarly, when the magnetic field 108 is reduced or removed, the ferromagnetic elements 128 and remainder of the band 106 return from the second arrangement back to the first arrangement.
[0090] In some embodiments, applying the magnetic field 108 via the external electromagnet 118 to the ferromagnetic elements 128 of the band 106 actuates (e.g., expands or constricts) substantially the entire band 106. For example, the magnetic field 108 may be applied across the entire band 106 or to each of multiple bands 106 of the intravascular device 102. In additional embodiments, applying the magnetic field 108 via the external electromagnet 118 to the ferromagnetic elements 128 of the band 106 actuates (e.g., expands or constricts) only a small segment of the band 106. For example, as previously discussed, the magnetic field 108 may be focused (e.g, concentrated) at a plane perpendicular to the longitudinal length (e.g, the axial length) of the band 106 of the intravascular device 102. In addition, the focused magnetic field may be steered to successively (e.g., sequentially or progressively) actuate and expand each band 106 along the axial length of the intravascular device 102 along the axial length of the thereof from the distal end to the proximal end. Thus, a single section of the of the intravascular device 102 may provide directional blood flow within the subject’s blood vessel(s). In further embodiments, applying the magnetic field 108 includes utilizing multiple electromagnets 118 arranged in series external to the subject. The multiple electromagnets 118 may be activated and / or deactivated in series to successively actuate (e.g. , expand) segments of the of the intravascular device 102 and the corresponding band 106 of the respective section. In some embodiments, the ends of the intravascular device 102 remain in an expanded state during actuation of the section(s) of the intravascular device 102 so as to prevent blood from accumulating and / or stagnating near the walls of the blood vessel (s) and to ensure that the intravascular device 102 remains in place within the blood vessel.
[0091] FIG. 7 is a front perspective view of an embodiment of an actuatable section of an intravascular device 102 in a first arrangement in accordance with embodiments of this disclosure. FIG. 8 is a front perspective view of the actuatable section of the intravascular device 102 of FIG. 7 in a second arrangement in accordance with embodiments of this disclosure Referring to FIGS. 7 and 8, in certain embodiments of the disclosure, the band 106 is in a constricted state (FIG. 8) in the first arrangement without a magnetic field 108 applied thereto, and in an expanded state (FIG. 7) in the second arrangement with a magnetic field 108 applied thereto.. However, as disclosed above, the disclosure is not so limited.
[0092] FIG. 9 is a cross-sectional view of the band 106 of the intravascular device 102 of FIGS. 7 and 8 taken along the 9-9 section line of FIG. 8. As show n in FIG. 9, the band 106 includes the ferromagnetic particles 130 dispersed within (e.g., embedded within) the additional flexible material 116. In addition, the band 106 may be a semi-annular or annular band that partially or fully surrounds the stent graft 104 of the intravascular device 102. In some embodiments, the band 106 includes a semi-annular or annular shape in the first arrangement (non-actuated state). In other embodiments, the band 106 includes a semi-annular or annular shape in the second arrangement (actuated state). In addition, the band 106 may comprise two or more separate components that may be combined together to at least partially encompass the stent graft 104 of the intravascular device 102.
[0093] In some embodiments, the band 106 may include the additional flexible material 116 interposed between an interior quantity of the ferromagnetic material (e.g., the ferromagnetic elements 128) and an exterior quantity of the ferromagnetic material. For example, the ferromagnetic elements 128 may be arranged on both an interior surface of the additional flexible material 116 and an exterior surface of the additional flexible material 116. In additional embodiments the ferromagnetic material (e.g, the ferromagnetic elements) may be concentrated on the exterior surface or the interior surface of the additional flexible material 116. For example, the ferromagnetic elements 128 may be on only a single side of the additional flexible material 116. In further embodiments, the ferromagnetic elements 128 may be embedded within and / or surrounded by the additional flexible material 116.
[0094] One or more of the embodiments may be combined such that each band 106 of the intravascular device 102 includes the ferromagnetic particles 130 of FIGS. 7-9 dispersed therethrough. In some embodiments, the stent graft 104 may be arranged laterally adjacent to the band 106 such that the stent graft 104 and the band 106 each extend the full length of the intravascular device 102. For example, the intravascular device 102 may include alternating of sections of the stent graft 104 and the band 106 arranged around the circumference of the intravascular device 102 (e.g., each section extending axially and alternating in the circumferential direction).
[0095] The band 106 may be formed in a vanety of ways. In some embodiments, the additional flexible material 116 may be formed of and / or comprise a thin sheet of flexible biocompatible polymer, such as ePTFE. In some embodiments, ferromagnetic material (e.g., the ferromagnetic elements 128 and / or the ferromagnetic particles 130) may be simultaneously integrated into the flexible biocompatible polymer during formation of the biocompatible polymer sheet. In additional embodiments, the thin sheet of flexible biocompatible polymer may be reinforced with metal wires (e.g., nitinol wires, stainless steel wires, etc.), and then a ferromagnetic material may be added to the flexible biocompatible polymer. In some embodiments, the ferromagnetic material (e.g., the ferromagnetic elements 128 and / or the ferromagnetic particles 130) are arranged in longitudinal sections to form a striped pattern that includes sections without ferromagnetic material and sections with ferromagnetic material. Lateral ends of the additional flexible material 116 may then be secured together to form a tubular shape, as shown.
[0096] The intravascular device 102 may be positioned, for example, in the subject’s descending aorta below' (e.g. , downstream of) the subject’s renal arteries. Positioning the circulatory assist device in the subject’s descending aorta below the renal arteries may facilitate blood flow in the subject’s legs or lower body half to avoid limb amputation. In some embodiments, the band 106 may be in the first arrangement (e.g., the nonactuated state) when the subject’s heart is in diastole. In additional embodiments, the band 106 may be in the first arrangement (e.g., the non-actuated state) when the subject’s heart is in systole. In further embodiments, the band 106 may be in the first arrangement (e.g., the nonactuated state) until the subject’s descending aorta pulses due to contractions of the subject’s heart. Accordingly, the band 106 may be in the first arrangement (e.g., the non-actuated state) until slightly after the heart is in systole because the pulsatile movement of the descending aorta below the renal arteries is slightly delayed relative to the heart being in systole.
[0097] In certain embodiments, the circulatory assist device may be positioned in the subject’s descending aorta above (e.g., upstream of) the subject’s renal arteries. Positioning the circulatory assist device 100 in the subject’s descending aorta above the renal arteries may help heart failure patients with excess body fluid to remove that fluid by accelerating pulsatile flow into the kidneys.
[0098] In some embodiments, blood from the subject’s heart may be directed down through the subject’s descending aorta due to the constriction and / or suction force resulting from the constriction and expansion of the band 106 of the intravascular device 102.
[0099] In further embodiments, the circulatory assist device 100 may be used in hemodialysis patients to avoid blood clot formations in arterio-venous grafts and fistulas as well as central venous lines. In some embodiments, circulatory assist device 100 may be used in Inferior Vena Cava to improve venous return to the heart in conditions such as venostasis due to chronic venous insufficiency, venous hypertension or in patients that are paralyzed or bedridden for other reasons.
[0100] FIG. 10 is a schematic illustration of an embodiment of the circulatory assist device 100 of FIG. 1, including electrical components 134, 136, 138, configured to interact with the circulatory assist device 100. As shown in FIG. 10, the circulatory assist device 100 includes the band 106 (e.g. , the actuatable portion) of the intravascular device 102, the one or more electromagnets 118, an external controller 134, an external timing device 136, and / or a power supply 138 that are each in electronic communication with one another.
[0101] The external controller 134 includes a processor and memory. The external controller 134 is configured to activate and deactivate the external power supply 138 to activate and deactivate the one or more electromagnets 118.
[0102] The external timing device 136 may be a pacemaker or an electrocardiogram (ECG). Accordingly, the external timing device 136 may indicate when the subject’s heart is in systole and in diastole. The external controller 134 may monitor the external timing device 136 to determine the timing of the constriction and expansion of the subject’s heart, which can then be utilized by the external controller 134 to activate and deactivate the one or more electromagnets 118. In some embodiments, the external controller 134 may activate the one or more electromagnets 118, and consequently, cause the band 106 to actuate, when the subject’s heart is in diastole. In additional embodiments, the external controller 134 may activate the one or more electromagnets 118, and consequently, cause the band 106 of the intravascular device 102, when the subject’s heart is in systole. Thus, the actuation of the band 106 of the intravascular device 102 may be synchronized with the timing of the subject’s heartbeat to facilitate pulsatile flow.
[0103] FIG. 11 is a perspective view of an embodiment of the circulatory assist device 140 of FIG. 1 including an outer member 144 in accordance with embodiments of this disclosure. FIG. 12 is a perspective view of the circulatory assist device 140 of FIG. 11 with the outer member 144 removed illustrating an inner member 146 thereof. In various embodiments, the circulatory assist device 140 includes an intravascular device 142, which includes an outer member 144 (FIG. 11) and an inner member 146 (FIG. 12). The circulatory assist device 140 is configured to be inserted into the subject’s blood vessel(s) to facilitate pulsatile blood circulation within the subject (e.g., functioning as a pump to assist the subject’s heart).
[0104] Referring collectively to FIGS. 11 and 12, the circulatory assist device 140 includes a distal end 148 (e.g., drive end), a proximal end 150 (e.g, a docking end), and the intravascular device 142 between the distal end 148 and the proximal end 150. When the intravascular device 142 is assembled, the inner member 146 (FIG. 12) is positioned within, radially inward of, and coaxially aligned with the outer member 144 (FIG. 11) about a central longitudinal axis 152 of the intravascular device 142.
[0105] The intravascular device 142 is sized for insertion into a blood vessel of the subject as described herein. A longitudinal length of the intravascular device 142 may vary depending on where the intravascular device 142 will be located within the subject during use (e.g., the specific blood vessel the intravascular device 142 will be positioned within during use). As non-limiting examples, the intravascular device 142 may have a longitudinal length within a range of from about 2 centimeters (cm) to about 20 cm, such as from about 4 cm to about 15 cm, or from about 5 cm to about 10 cm (e.g., about 8 cm). In addition, the outer diameter of the intravascular device 142, when fully expanded, may be within a range of from about 10 millimeters (mm) to about 26 mm, such as from about 15 mm to about 24 mm, from about 18 mm to about 22 mm (e.g., about 20 mm or about 22 mm).
[0106] As discussed above, the intravascular device 142 may be compressible and expandable. The intravascular device 142 is configured with sufficient flexibility to facilitate introduction and removal into the subject’s blood vessels and sufficient rigidity to brace against the interior walls of the subject’s blood vessel(s) to secure the intravascular device 142 within the subject’s blood vessel and inhibit (e.g., prevent) the intravascular device 102 from migrating along the subject’s blood vessel.
[0107] In some embodiments, the intravascular device 142 and / or portions of the intravascular device 142 may be biased to expand radially outw ard such that the intravascular device 142 contacts the walls within the subject’s blood vessel once the intravascular device 142 is positioned in a desired location. In some embodiments, the outer member 144 and / or the inner member 146 include a reinforcing structure that may bias the intravascular device 142 into the expanded position. In additional embodiments, the intravascular device 142 may include additional reinforcing elements 154 that extend from the distal end 148 to the proximal end 150 of the circulatory assist device 140. The additional reinforcing elements 154 may include, for example, wire-like elements made of a biocompatible material, such as nitinol, and may be arranged to form a cage. The additional reinforcing elements 154 may further act to bias the intravascular device 142 into an expanded state.
[0108] As shown in FIG. 11, in various embodiments, the outer member 144 includes a flexible material 156 and a reinforcing structure 158 that provides rigidity' to the outer member 144 and the intravascular device 142. In addition, the outer member 144 may be biased to expand radially outward. For example, the reinforcing structure 158 may function similar to a spring that stores energy when a force (e.g. , a compressive force) is applied to constrict the outer member 144, and then the outer member 144 expands when the force is no longer applied to constrict the outer member 144.
[0109] The reinforcing structure 158 may be a mesh, w eave, braid, etc., or a pattern of wirelike elements that are arranged to form the reinforcing structure 114. In some embodiments, the reinforcing structure 158 may include nitinol wires arranged with alternating bends to form a zigzag or other shape extending circumferentially around the outer member 144. In addition, the reinforcing structure 158 may be made of any suitable biocompatible material, such as a polymer, metal, etc. In some embodiments, the reinforcing structure 158 may be coated with another material, such as, for example a biocompatible polymer like ePTFE.
[0110] The flexible material 156 may serve as an artificial blood vessel wall. The flexible material 156 may be made of any suitable biocompatible material, such as a biocompatible polymer. As a specific, non-limiting example, the flexible material 156 may comprise ePTFE.
[0111] As shown in FIG. 12, in various embodiments, the inner member 146 includes a stent graft 160 and one or more bands 162 (e.g., one or more selectively actuatable sections) configured to be selectively actuated by application of a magnetic field 108. As shown, the inner member 146 may include multiple sections, each section including a respective band 162 (three shown). However, the disclosure is not so limited. The inner member 146 may include any number of bands 162, such as a single band 162, or even tens of bands 162, such as 30 bands 162. When the intravascular device 142 is in the assembled state, at least a portion of the inner member 146 may be secured to the outer member 144. For example, the section(s) of the stent graft 160 of the inner member 146 may be secured to the outer member 144, and each of the bands 162 of the inner member 146 may remain free to move (e.g., radially relative to the outer member 144).
[0112] The stent graft 160 of the inner member 146 of the intravascular device 142 may be substantially identical to the embodiments of stent graft 104 of the intravascular device 102 previously shown and described in FIGS. 1-9. Similarly, the one or more bands 162 of the inner member 146 of the intravascular device 142 may be substantially identical to the embodiments of the band(s) 106 of the intravascular device 102 previously shown and described in FIGS. 1-9. Thus, the stent graft 160 may include a flexible material 164 and a reinforcing structure 166 that are substantially identical to the flexible material 112 and the reinforcing structure 114, respectively, of the stent graft 104. Additionally, the band(s) 162 may include an additional flexible material 168 and ferromagnetic material (e.g., ferromagnetic elements 170 and / or ferromagnetic particles 172) that are substantially identical to the additional flexible material 116 and the ferromagnetic material (e.g., the ferromagnetic elements 128 and / or the ferromagnetic particles 130), respectively, of the band(s) 106.
[0113] The inner member 146 may additionally include one or more electrically conductive element(s) 174 (e g., one or more wire(s)) that extends from the distal end 148 along the entire length of the intravascular device 142. The electrically conductive element(s) 174 may be on an exterior surface and / or interior surface of the inner member 146. In additional embodiments, the electrically conductive element(s) 174 may be radially within the inner member 146 (as shown and described with reference to FIGS. 17-31). The electrically conductive element(s) 174 may be any electrically conductive material. As non-limiting examples, the electrically conductive element(s) 174 may comprise copper, silver, carbon nanotubes, nitinol, etc., which may be coated in a biocompatible insulative material.
[0114] The electrically conductive element 174 may be electrically connected to an internal battery 176 at the distal end 148 of the circulator}' assist device 140. The distal end 148 of the circulatory assist device 140 may additionally include internal electronics 178 (shown and described in FIG. 33), which may include a wireless charging coil, a communication circuit, a control circuit, sensor(s) and / or timing device(s). The distal end 148 may comprise a canister covering and sealing the internal battery 176 and the internal electronics 178. In some embodiments, the canister may comprise titanium. In additional embodiments, the canister may comprise at least a portion that is made of a material that is transparent to certain frequencies of electromagnetic radiation, magnetic fields, and / or electrical fields, such as a ceramic or a polymer, to facilitate electromagnetic, electric, and / or magnetic communication between devices located outside of the patient’s body and components within the distal end 148. Accordingly, the wireless charging coil (e.g., a receiving coil) may be inductively coupled to an external transmission coil external to the subject such that the wireless charging coil can receive electromagnetic waves transmitted from the external transmission coil and through the subject’s skin, tissue, blood vessel(s), and blood to the wireless charging coil. The electromagnetic waves received by the wireless charging coil within the subject’s blood vessel(s) may be used to charge the internal battery 176 and / or power the internal electronics 178, such as via a communication circuit and a control circuit. In addition, the internal battery 176 and / or the internal electronics 178 (e.g., the wireless charging coil, the communication circuit, and the control circuit) may be utilized to selectively actuate the band 162 of the inner member 146 of the intravascular device 142.
[0115] The distalmost portion of the distal end 148 may have a smooth, generally dome shaped, leading end. This may prevent harm to the patient should the distal end 148 come into contact with the arterial wall, such as during an insertion or removal procedure.
[0116] The proximal end 150 of the circulatory' assist device 140 may include one or more features to facilitate insertion and removal of the circulatory assist device 140 within a subject’s blood vessel(s). As shown in FIGS. 11 and 12, the proximal end 150 of the circulatory assist device 140 may include a circumferential groove 180 and a hemispherical recess 182 within the proximal most end to facilitate connections between the proximal end 150 and an insertion and / or removal catheter for introduction and removal of the circulatory assist device 140 within the subject’s blood vessel (s). For example, the insertion and removal catheter may include corresponding features configured to connect to the circumferential groove 180 and / or the hemispherical recess 182 to firmly secure the circulatory assist device 140 to the insertion catheter for introduction to the subject’s blood vessel(s), and to firmly secure the circulatory assist device 140 to the removal catheter for removal from the subject’s blood vessel(s). As anon-limiting example, the insertion and removal catheters may be similar to those described in (e.g., FIGS. 21 and 22) of U.S. Patent Publication No. 2021 / 0077687 to Leonhardt (Mar. 18, 2021).
[0117] Once the device is positioned in a desired location within the subject’s blood vessel(s), e.g., in the subject’s ascending aorta, the subject’s descending aorta (above or below the renal arteries), and / or in any other suitable artery or vein, the circulatory assist device 140 may be actuated to, for example, facilitate blood circulation.
[0118] FIG. 13 shows the inner member 146 of the circulatory assist device 140 of FIG. 12 in a first arrangement (anon-actuated state). FIG. 14 shows the inner member 146 of FIG. 13 in a second arrangement (an actuated state). As shown in FIG 14, one or more electromagnets 118 are configured to electromagnetically or magnetically couple (e.g., inductively couple) to the internal electronics 178. For example, the one or more electromagnets 118 (e.g., the transmission coil) are configured to provide electromagnetic energy to the wireless charging coil (e.g., the receiving coil), which is then converted to electrical energy (e g., current) used to power and / or operate the circulatory assist device 140. For example, each band 162 of the circulatory assist device 140 may be independently actuatable utilizing electric current passed through the electrically conductive element(s) 174, which may result in an internal magnetic field within the interior of the inner member 146 of the circulatory assist device 140.
[0119] FIG. 15 shows a simplified longitudinal cross-sectional view of the inner member 146 of the circulatory assist device 140 of FIG. 12. FIG. 16 shows a simplified axial cross-sectional view of the inner member 146 of the circulatory assist device 140 of FIG. 12. For simplicity, FIGS. 15-1 show only a single band 1 2 between two sections of the stent graft 160. However, as previously noted, the intravascular device 142 of the circulatory assist device 140 may include any desired number of bands 162, such as only single band 162, or multiple bands 162 (as shown in FIGS. 11-14). As shown in FIGS. 15-16, in various embodiments, the electrically conductive element(s) 174 extends longitudinally (e.g., along the length) through the center of the inner member 146 of the intravascular device 142. The outer member 144 is configured to contact and remain in contact with the subject’s blood vessel wall, and the stent graft 160 of the inner member 146 is configured to remain substantially stationary. Each band 162 of the inner member 146 is configured to move (e.g., radially inward) relative to the outer member 144 and the stent graft 160 of the inner member 146. In addition, each band 162 of the inner member 146 includes ferromagnetic material (e g., the ferromagnetic elements 170 and / or the ferromagnetic particles 172). As shown in FIG. 16, the ferromagnetic material of the band 162 may be concentrated on at least a portion (e.g., a portion, a substantial portion, or the entirety of) of the circumference of the respective band 162 of the intravascular device 142. Arrangement and concentration of the ferromagnetic material of the band 162 will determine the resulting shape of the fluid envelope during actuation of each respective band 162. Accordingly, the areas of each respective band 162 that include ferromagnetic material may be tailored based on the specific application to optimize the shape of the fluid envelope while the respective band 162 of the intravascular device 142 is actuated and constncted.
[0120] The electrically conductive element(s) 174 is electrically connected to one or more internal electromagnets 184 (e.g., wire coils, optionally, wrapped around a core material) within the inner member 146. As current passes from the internal battery 176 and / or the internal electronics 178 to the electrically conductive element(s) 174 and through the internal electromagnets 184, an internal magnetic field 186 is generated, which attracts the ferromagnetic material of each respective band 162 radially inward and toward the internal electromagnets 184 (or alternatively repels the ferromagnetic material of each respective band 162 radially outward and away from the internal electromagnets). Accordingly, in some embodiments, each respective band 162 is actuated in response to current passing through respective internal electromagnets 184 positioned and arranged to cause a magnetic field 186 to be applied to the respective band 162 associated therewith. As shown in FIGS. 15-16, in some embodiments, each band 162 in the first arrangement is non-actuated and in a relaxed and expanded state (shown in a solid line) and in the second arrangement is actuated and in a constricted state (shown in a dashed line) while the internal magnetic field 186 is applied thereto.
[0121] Although illustrated as being expanded in the first arrangement (non-actuated / relaxed state) and constricted in the second arrangement (actuated state), in some embodiments, the band 162 may be configured to be constricted in the first arrangement (non-actuated / relaxed state) and expanded in the second arrangement (actuated state). In such embodiments, when current is applied to the internal electromagnets 184, the internal magnetic field 186 repels the ferromagnetic material of the band 162 and causes each band 162 to expand.
[0122] In some embodiments that include multiple bands 162 (e.g., the embodiments shown in FIGS. 11-14), each of the bands 162 of the intravascular device 142 are independently actuatable. Each of the bands 162 may include one or more respective internal electromagnets 184 that can be successively (e.g., sequentially) actuated to facilitate directional blood flow within the subject’s blood vessel(s). For example, a first band 162 may include one or more respective internal electromagnets 184, a second band 162 may include one or more additional respective internal electromagnets 184, a third band 162 may include one or more yet additional respective internal electromagnets 184, etc. The electrically conductive element(s) 174 may also include switches and / or separate wiring for each band 162 to facilitate the independent actuation of the respective band 162. In some embodiments, the ends of the intravascular device 142 may remain in an expanded state dunng actuation of the bands 162 so as to prevent blood from accumulating and / or stagnating near the walls of the blood vessel(s) and to maintain contact with the wall of the blood vessel(s) to maintain a position of the intravascular device 142 therein.
[0123] FIGS. 17-21 show an embodiment of the intravascular device 142 of the circulatory assist device 140 of FIGS. 11 and 12. FIG. 17 shows an exploded view of the circulatory assist device 140 of FIGS. 11 and 12. For testing purposes, an Arduino Uno R3 microcontroller was utilized to perform the same functions that the control circuit of the internal electronics 178 (FIGS. 11-14) perform during operation of the circulatory assist device 140.
[0124] As shown in FIG. 17, the outer member 144 is divided into two separate components located on ends of the disassembled inner member 146. The inner member 146 of the intravascular device 142 shown includes flexible material 187 (e.g., the flexible material 164, and the additional flexible material 168 with the ferromagnetic material incorporated into longitudinal sections the additional flexible material 168), the internal electromagnets 184, and a central support member 188. Accordingly, the inner member 146 includes sections of the stent graft 160 laterally adjacent to respective bands 162 arranged around the circumference of the flexible material 187. The inner member 146 additionally includes the internal electromagnets 184 (six shown) arranged on a central support member 188. The inner member 146 may additionally include two end caps 190 configured to connect to ends of the central support member 188 and the flexible material 187. The central support member 188 and the end caps 190 may comprise any suitable biocompatible material (e.g., biocompatible plastics, ceramics, metals, etc.) and may be formed via conventional manufacturing or additive manufacturing (e.g., 3D printing). The disassembled components of the inner member 146 may be arranged together and assembled to arrive at the inner member 146 of the intravascular device 142 in the assembled state, shown in FIGS. 18 and 19.
[0125] Referring now to FIGS. 18 and 19, the central support member 1 8, including the internal electromagnets 184 is arranged within the central cavity of the inner member 146 of the intravascular device 142, and the end caps 190 are secured to ends of the central support member 188 and ends of the flexible material 187 to secure the central support member 188 to the flexible material 187. Electrical leads from the internal electromagnets 184 may be arranged on respective sides and fed out of the inner member 146 to form at least a portion of the electrically conductive element(s) 174. As previously discussed, the electrically conductive element(s) 174 may also include switches to electrically isolate each internal electromagnet 184 from one another such that each internal electromagnet 184 can be independently actuated
[0126] FIG. 20 shows a cross-section of the inner member 146 without the internal electromagnets 184 (FIG. 17). As shown in FIG. 20, in the assembled state, the flexible material 187 (including the ferromagnetic material incorporated into the bands 162) and the central support member 188 are coaxially aligned and connected to the end caps 190 at each end of the inner member 146 of the intravascular device 142.
[0127] FIG. 21 shows a perspective view of the central support member 188 of the inner member 146 without the internal electromagnets 184 (FIG. 17). In various embodiments, the central support member 188 includes dividers 192 (e.g., fins) creating separate sections 194 of the central support member 188. Each section 194 of the central support member 188 is configured to support a separate internal electromagnet 184 or a separate group of electromagnets 184. In addition, the central support member 188 includes a central cavity 196 that runs the length of the central support member 188. The central cavity 196 is configured to receive an optional core material 198 (e.g., a core for the internal electromagnets 184). The optional core material 198 may further increase the internal magnetic field 186 generated by one or more of the internal electromagnets 184. For example, the optional core material 198 may comprise iron or suppression beads (such as EMI Suppression Beads commercially available from Fair Rite at PO Box 288, One Commercial Row, Wallkill, NY 12589) arranged within the central cavity 196 of the central support member 188.
[0128] FIGS. 22 and 23 show an embodiment of the ferromagnetic material (e.g., the ferromagnetic element 170) isolated from the band 162 of the intravascular device 142 when no magnetic field is applied (FIG. 13), and when a magnetic field is applied (FIG. 14) illustrating a deflection thereof.
[0129] As shown in FIGS. 22 and 23, the ferromagnetic material comprises the ferromagnetic element 170 held taut between two secured ends. The ruler illustrates an amount of the deflection of the ferromagnetic element 170 when a magnetic field is applied. As shown in FIG. 23, a stack of neodymium (NdFeB) magnets is positioned in close proximity to the ferromagnetic element 170. When the applied magnetic field is large enough, the ferromagnetic element 170 deflects such that a portion of the ferromagnetic element 170 contacts the stack of neodymium magnets. As shown from the ruler in FIG. 23, a portion of the ferromagnetic element 170 is attracted about 9 mm using the neodymium magnets.
[0130] The stack of neodymium magnets used for this test includes about 24 !4-inch (62.23 cm)-by-' / 4-inch (0.64 cm) cylindrical neodymium magnets. The magnetization is in the axial direction, and the surface field of an individual magnet may be from about 3,000 Gauss (0.3 Tesla) to about 5000 Gauss (0.5 Tesla), such as about 3,315 Gauss (0.3315 Tesla) or about 4,667 Gauss (0.4667 Tesla). However, since multiple magnets are combined together, the magnetic field may be slightly larger than an individual magnet. However, since magnetic field strength vanes with distance, each additional magnet is further from the ferromagnetic element 170, thus each additional magnet contributes less to the additional magnetic field.
[0131] FIG. 24 is a table showing deflection distances of the ferromagnetic material of the band 162 (FIGS. 12, 17) resulting from different configurations of the internal electromagnets positioned within the inner member 146 (FIG. 12) of the intravascular device 142 (FIG. 12). As shown from the table, suppression beads were generally ineffective as a core material for resulting in the attraction, which may also be due to the low number of turns in the embodiments utilizing suppression beads. In additional embodiments, the internal electromagnets 184 (FIGS. 15, 17) included a 10 mm diameter iron core surrounded by wire coils. The wire coils included gauge ranges from 24 to 36 and the number of turns ranged from 48 up to 420 turns. The length of the wire coils ranged from 30 mm to 50 mm. The current applied to the wire coils was set at 3 Amps. As shown from FIG. 24, the greatest magnetic field strength was achieved with 420 turns and a coil length of 35 mm. This configuration generated a magnetic field of about 9.04 Tesla (T), and resulted in pulling the ferromagnetic material of the band 162 a distance of about 10 mm.
[0132] FIG. 25 is another table illustrating magnetic force calculations resulting from manipulating additional variables of the internal electromagnets 184 (FIGS. 15. 17). As shown in FIG. 25, calculations included a variety of wire gauges ranging from 24 AWG to 38 AWG, current varying from 3.5 Amps to 0.1143 Amps, the number of coil turns ranging from 137 to 3062, the length of the wire ranging from 2 cm to about 48 cm.
[0133] FIG. 26 is a graph illustrating the relationship between magnetomotive force and wire gauge for the internal electromagnets. As shown in FIG. 26, the potential power generally decreases as the wire gauge increases. In other words, the potential power generally decreases as the diameter of the wire utilized in the internal electromagnets decreases.
[0134] FIG. 27 is a graph illustrating the relationship between potential power and wire gauge for the internal electromagnets. As shown in FIG. 27, the magnetomotive force generally decreases as wire gauge increases. In other words, the magnetomotive force generally decreases as the diameter of the wire utilized in the internal electromagnets 184 decreases.
[0135] Taking everything into account, the internal electromagnets 184 (FIGS. 15, 17) may be circular and / or square coils with anywhere from about 10 turns to about 1000 turns of wire, such as about 100 turns, about 200 turns, about 300 turns, about 400 turns, about 500 turns, about 600 turns, about 700 turns, about 800 turns, about 900 turns, or about 1000 turns. The coils may be made of copper wire or other conductive metal wire w ith a diameter within a range of from about 0.0799 mm (e.g. , 40 American Wire Gauge (AWG)) to about 2.588 mm (about 10 AWG), such as, for example about 0.812 mm diameter (about 20 AWG) or about 0.255 mm (about 30 AWG). The winding space of the coil may be from about 1-cm to about 10-cm wide (e.g., 5 cm wide), and the inner diameter of the windings may be from about 5 mm cm to about 10 mm, such as about 5 mm, about 6 nun, or about 7 mm. As a specific non-limiting example, one or more of the internal electromagnets 184 may include 4-mm-diameter iron cores surrounded by coils comprising about 0.202 mm (about 32 AWG) diameter wire arranged into about 750 turns, with a total coil length of about 10 mm.
[0136] FIG. 28 is a chart illustrating the magnetic field (e.g., the magnetic flux density) within the inner member 146 (FIGS. 12, 17) when the internal electromagnets 184 (FIGS. 15, 17) are activated. More particularly, FIG. 28 shows the magnetic field generated by the internal electromagnets 184 when 1.5 Amps of current is circulating through the internal electromagnets 184 that include 4 mm diameter iron cores surrounded by coils comprising about .202 mm (about 32 AWG) diameter wire arranged into about 750 turn coils, with total coil lengths of about 10 mm. FIG. 28 also shows the impact of the resulting magnetic field on the central support member 188 (FIGS. 17, 20) and the ferromagnetic material of the band 162 (e.g., of the additional flexible material 168 (FIGS. 12, 17)) of the intravascular device 142 (FIGS. 12, 17). The magnetic field is shown with the internal electromagnets 184 supported on the central support member 188. From the results shown in FIG. 28, the maximum magnetic flux density applied to the additional flexible material 168 is about 1.0 Tesla.
[0137] FIG. 29 illustrates results from a finite element analysis of simulated blood flow through the inner member 146 (FIGS. 12, 17) of the intravascular device 142 (FIGS. 13, 17) in the expanded state. The peak velocity of blood flow is achieved roughly equidistantly between the central support member 188 (FIGS. 17, 20) and the inner wall of the additional flexible material 168 (FIGS. 12, 17), with areas of low flow velocity occurring near the central support member 188 and the inner wall of the additional flexible material 168.
[0138] FIG. 30 illustrates results from a non-linear analysis of simulated blood flow through the inner member 146 (FIGS. 12, 17) of the intravascular device 142 (FIGS. 12, 17) in the constncted state. As shown in FIG. 30, the boundary conditions are that each end is fixed in place, the internal pressure is 80 millimeters of Mercury (mmHg), and 1.0 Newton (N) of force is applied alternately from left, center, and right. The results demonstrate that the additional flexible material 168 (including the ferromagnetic material) of the band 162 (FIGS. 12, 17) of the intravascular device 142 deflects (e.g., constricted) by about 4 mm when actuated (e.g., when the internal magnetic field 186 (FIGS. 27, 28) is applied). Additionally, when the internal magnetic field 186 is removed, and the band 162 returns to the relaxed state, the additional flexible material 168 of the inner member 146 returns to the expanded state.
[0139] FIG. 31 shows a schematic view of the internal electronics 178 of the intravascular device 142 of the circulatory assist device 140. The internal electronics 178 includes an internal controller 200 in electronic communication with the internal battery 176, a wireless charging coil 202, a series of switches 220, and the internal electromagnets 184 (six show n ). The internal electronics 178 may optionally include one or more sensor(s) 222 (two shown) and / or an internal timing device 224.
[0140] While only two sensors 222 are shown, the circulatory assist device 140 may include any number of sensors. The sensor(s) 222 may include any type of sensors that may be useful for detemtining blood flow characteristics and parameters that may relate to the health of the subject and / or the operation of the circulatory assist device 140. For example, the sensor(s) 222 may include a pressure sensor, a temperature sensor, and / or a fluid flow sensor, etc.
[0141] Although six internal electromagnets 184 are shown, the circulatory' assist device 140 may include any desired number of internal electromagnets 184. The internal electromagnets 184 may each include individual switches 220 such that each of the internal electromagnets 184 can be independently actuated. Each of the switches 220 are connected to the internal battery 176 (e.g., a power source) and the internal controller 200, and each of the switches 220 may toggle between an on position (where current flows to the respective internal electromagnet 184) and an off position (where no current flows to the respective internal electromagnet 184). To toggle the switches 220 between the off and on positions, each of the switches 220 may include a solenoid to which power can be toggled on or off by the internal controller 200. The resulting magnetic field generated by the solenoid attracts the switch to the on position, and the switch returns to the off position when no magnetic field is applied. When one of the internal electromagnets 184 is in the on position, current flows to the respective internal electromagnet 184 to activate it and generate and / or contribute to the internal magnetic field 186. Thus, each of the internal electromagnets 184 may be independently controlled so the internal electromagnets 184 may be toggled on and off in any desired manner (e.g., in sequence, all at the same time, etc.).
[0142] The internal timing device 224 may include a pacemaker or an electrocardiogram (ECG). Accordingly, the internal timing device 224 may indicate when the subject’s heart is in systole and in diastole. The information from the internal timing device 224 may be utilized by the internal controller 200 to independently activate and deactivate the internal electromagnets 184. For example, the internal controller 200 may monitor the internal timing device 224 to determine the timing of the constriction and expansion of the subject’s heart, which can then be utilized by the controller to activate and deactivate the internal electromagnets 184.
[0143] The circulatory assist device 140 may initially be positioned within the subject’s blood vessel(s), and then the internal electromagnets 184 may be activated to actuate the bands 162 of the intravascular device 142 of the circulatory assist device 140 to facilitate pulsatile blood flow within the subject’s blood vessel(s). For example, one or more of the internal electromagnets 184 may be activated to generate the internal magnetic field 186. To activate one or more of the internal electromagnets 184, the controller 200 and / or the external controller 134 (described below with reference to FIG. 33) may be utilized to send current independently (e.g., selectively) to the internal electromagnets 184, such as, for example, by toggling the switches 220 controlling the power supply to each of the respective internal electromagnets 184 to actuate respective bands 162 associated therewith.
[0144] FIG. 32 shows an illustrative method 210 of facilitating pulsatile blood flow within a subject’s blood vessel(s). The method 210 includes inserting the circulatory assist device 140 within the subject’s blood vessel(s) 212. The circulatory assist device 140 may also be positioned within a desired location in the subject’s blood vessel (s) and deployed to an operational state.
[0145] The method 210 also includes activating a first internal electromagnet 184 to generate at least a portion of the internal magnetic field 214. For example, the internal controller 200 may send a control signal to turn on the first switch 220, which may activate the first internal electromagnet 184. The method 210 may also, optionally, include waiting a duration of time (e.g., about 0.1 second, 0.25 seconds, 0.5 second, 0.75 seconds, 1 second, etc.) with the first internal electromagnet 184 being active.
[0146] The method 210 additionally includes deactivating the first internal electromagnet 184 to remove the at least a portion of the internal magnetic field 186 generated by the first internal electromagnet 216. For example, the internal controller 200 may send a control signal to turn off the first switch 220 to deactivate the first internal electromagnet 184.
[0147] The method 210 further includes activating the second internal electromagnet 184 to generate at least a portion of the internal magnetic field. For example, the internal controller 200 may send a control signal to turn on the second switch 220, which may activate the second internal electromagnet 184. The method 210 may also, optionally, include waiting a duration of time (e.g., about 0.1 second, 0.25 seconds, 0.5 second, 0.75 seconds, 1 second, etc.) with the second internal electromagnet 184 being active.
[0148] The method 210 yet further includes deactivating the second internal electromagnet 184 to remove the at least a portion of the internal magnetic field 186 generated by the second internal electromagnet 184 at switch 220. For example, the internal controller 200 may send a control signal to turn off the first switch 220 to deactivate the second internal electromagnet 184.
[0149] The method 210 may include activating, waiting, and deactivating any number of additional internal electromagnets 184 (e.g., the third through the sixth internal electromagnets 184 shown in FIG. 17) in substantially the same manner. Thus, the method 210 may sequentially activate each electromagnet to facilitate directional pulsatile blood flow within the subject’s blood vessel(s). In some embodiments, the ends of the intravascular device 142 may remain in an expanded state during actuation of each band 162 so as to prevent blood from accumulating and / or stagnating near the walls of the blood vessel(s).
[0150] The same processes can be utilized to activate and deactivate any number of the internal electromagnets 184. Accordingly, the internal electromagnets 184 may be activated and deactivated as desired to facilitate directional blood flow within the subject’s blood vessel(s). Tn some embodiments, the internal electromagnets 184 may all be activated simultaneously. In additional embodiments, pairs of internal electromagnets 184 may be activated and deactivated. In further embodiments, one or more of the internal electromagnets 184 may remain activated while the other internal electromagnets 184 are operated in sequence. The independent operation of the internal electromagnets 184 enables the user to program any desired operation of the intravascular device 142 of the circulatory assist device 140.
[0151] In certain embodiments, the circulatory assist device is positioned with the intravascular device in the subject’s descending aorta above (e.g., upstream of) the subject’s renal arteries. For example, the external electromagnet 118 may transcutaneously transmit power and control signals via an electromagnetic field or the magnetic field 108 to the circuitry within the subject (as described in FIG. 33 below). Positioning the circulatory assist device 140 in the subject’s descending aorta above the renal arteries may help heart failure patients with excess body fluid to remove that fluid by accelerating pulsatile flow into the kidneys.
[0152] In some embodiments, the band 162 may be in the relaxed state (e.g., the expanded state) when the subject's heart is in diastole. In additional embodiments, the bands 162 may be in the relaxed state when the subject’s heart is in systole. In further embodiments, the bands 162 may be in the relaxed state until the subject’s descending aorta pulses due to contractions of the subject’s heart. Accordingly, the bands 162 may be in the relaxed state until slightly after the heart is in systole because the pulsatile movement of the descending aorta below the renal arteries is slightly delayed relative to the heart being in systole.
[0153] Tn some embodiments, the bands 1 2 are in the actuated state (e.g., the constricted state) when the subject’s heart is in systole. In additional embodiments, the bands 162 may be in the actuated state when the subject’s heart is in diastole. In further embodiments, the bands 162 may be actuated and constricted when the subject’s descending aorta pulses due to contractions of the subject’s heart. Accordingly, the bands 162 may be actuated slightly after the heart is in systole because the pulsatile movement of the descending aorta below the renal arteries is slightly delayed relative to the heart being in systole. Accordingly, blood from the subject’s heart may be directed down through the subject’s descending aorta due to the constriction and / or suction force resulting from the constriction and expansion of the bands 162 of the intravascular device 142.
[0154] In further embodiments, the circulatory assist device 140 may be used in hemodialysis patients to avoid blood clot formations in arterio-venous grafts and fistulas as well as central venous lines. In some embodiments, circulatory assist device 140 may be used in the inferior vena cava to improve venous return to the heart in conditions such as venostasis due to chronic venous insufficiency, venous hypertension or in patients that are paralyzed or bedridden for other reasons.
[0155] FIG. 33 shows a schematic view of the circulatory assist device 140, according to embodiments of this disclosure. As shown in FIG. 33, the circulatory assist device 140 includes components that remain external to the subject during operation. For example, the circulatory assist device includes an external electromagnet 118 (e.g., a transmission coil), the external controller 134, the external power supply 138, and optionally an external timing device 136, that are each in electronic communication with one another. The external electromagnet 118 is configured to inductively couple to the wireless charging coil 202 (e.g., the receiving coil) within the distal end 148 of the circulatory assist device 140 that is configured to be within the subject’s blood vessel(s). Accordingly, the external electromagnets 118 is configured to send electromagnetic and / or magnetic waves (e.g., the magnetic field 108) to wirelessly (e.g., transcutaneously) transmit power and / or control signals to the wireless charging coil 202 and / or other components of the internal electronics 178, such as the internal controller 200. The external electromagnet 118 and the wireless charging coil 202 may be similar to that utilized in any of the following references: U.S. Patent 9,642,958 to Zilbershlag et al. (May 9, 2017); Khan, Sadeque Reza et al. “Wireless Power Transfer Techniques for Implantable Medical Devices: A Review.” Sensors (Basel, Switzerland) vol. 20,12 3487, 19 Jun. 2020, doi: 10.3390 / s20123487, U.S. Patent 9,308,303 to Badstilbner et al. (April 12, 2016); U.S. Patent Publication 20140378742 to Badstilbner et al. (Dec. 25, 2014); U.S. Patent 8,764,621 to Badstilbner et al. (July 1, 2014); and U.S. Patent Publication 20130289334 to Badstilbner et al. (Oct. 31, 2013). In some embodiments, the external controller 134 is configured to function as a primary controller, and the internal controller 200 is configured to act as a secondary controller that receives and executes instructions from the external controller 134. The external controller 134 may include a processor and / or a memory, and the external controller 134 may be configured to activate and deactivate the external power supply 138 to activate and deactivate the external electromagnet(s) 118.
[0156] The external timing device 136 may be a pacemaker or an electrocardiogram (ECG). Accordingly, the external timing device 136 may indicate when the subject’s heart is in systole and in diastole. The external controller 134 may monitor the external timing device 136 to determine the timing of the constriction and expansion of the subject’s heart, which can then be utilized by the controller to activate and deactivate the external electromagnet(s) 118. In some embodiments, the external controller 134 may activate the external electromagnet(s) 118 to send signals to the internal controller 200. The signals may instruct the internal controller 200 to actuate the bands 162 of the intravascular device 142, when the subject’s heart is in diastole. In additional embodiments, the signals may instruct the internal controller 200 to actuate the second potion of the intravascular device 102, when the subject’s heart is in systole. Thus, the actuation of the bands 162 of the intravascular device 142 may be synchronized with the timing of the subject’s heartbeat to facilitate pulsatile flow.
[0157] In additional embodiments, the external controller 134 is configured to function primarily to activate and deactivate the external electromagnets 118 to provide energy (e.g., electromagnetic energy or magnetic energy) to the wireless charging coil 202, and the internal controller 200 controls the operation of the intravascular device 142 (e.g., the actuation of the internal electromagnets 184 and the actuation of the bands 162 of the intravascular device 142). In such embodiments, the external timing device 136 may be omitted from the circulatory assist device.
[0158] In further embodiments, the external controller 134 may be configured to control certain aspects of operation of the circulatory assist device 140 (e.g., powering the implanted portion of the circulatory assist device 140, and sending control signals from an externally measured timing device (e.g., ECG or pacemaker)), while the internal controller 200 may be configured to control other aspects of operation of the circulatory assist device 140 (e.g., actuating the bands 162 of the intravascular device 142 via the internal electromagnets 184 and / or gathering sensor data related to blood flow rate and internal temperature that can then be transmitted back out to the external controller 134).
[0159] FIG. 34 illustrates a simulation of fin design with cuff (cuff with metal particles, see, e g., FIGS. 7-9) with a magnetic flux produced thereby.
[0160] In certain embodiments, the one or more electromagnets 118 each includes a cuff or puck shape. Each cuff- or puck-shaped electromagnet 118 may be surgically implanted in the patient sufficiently close to a respective band 106 for applying a magnetic field 108 thereto. See U.S. Patent Publication 20180000591 Al to Bonutti et al. (Jan. 4, 2018) for “Magnetic joint implant,” the contents of which are incorporated herein by this reference, for considerations of making an implantable electromagnet. Such an electromagnet produces an electromagnetic field upon powering.
[0161] In various embodiments, each electromagnet 118 includes a biocompatible exterior that encases the electromagnetic material. The electromagnet 118 may be shaped and configured to focus the generated magnetic field 108 on the respective band 106 for actuation and control thereof. In certain embodiments, the electromagnet 118 includes an array of electromagnets, which array can be onented, for instance, in opposition and at a 90-degree angle to a magnetic pole, which concentrates the field into a region of high intensity. U.S. Patent 5,929,732 to Bushman (July 27, 1999) for “Apparatus and method for amplifying a magnetic beam.”
[0162] The electromagnet itself may advantageously be powered and / or controlled by a transcutaneous energy-transfer (“TET”) unit. See, U.S. Patent 10,500,323 to Hewing et al. (Dec. 10, 2019) for “Systems and methods for fluid flows and / or presswes for circulation and perfusion enhancement,” the contents of which are incorporated herein by this reference. Such a TET unit typically includes (external to the patient): a battery pack or other energy sowce, external TET electronics, and a primary coil. Internal to the patient, the TET unit includes a secondary coil (for inductive coupling with the primary coil), internal TET electronics, and the electromagnet 118.
[0163] The circulatory assist device according to embodiments of the discloswe may be used in any application in any field where it is desired to move fluid particularly if pulsatility of flow is desired. For example, intravascular devices according to embodiments of the discloswe may be utilized for: an aorta circulatory assist pump, a heart wrap heart assist, leg and foot circulatory flow improvement, improving blood flow into kidneys via renal artery placement, improving blood flow to the eyes, improving blood flow to the brain, improving blood vessel compliance to reduce high blood pressure, improving strength and breathing of airway tubes, reducing blood clots during hemodialysis, and improving drug delivery including cancer therapies.
[0164] Embodiments of the disclosure offer improvements over other circulatory assist devices that have impellers which damage red blood cells and often reduce pulsatility of both blood flow and blood vessel wall movement. Such devices often have blood clots form within them thus blocking flow. External vessel systems can cause damage to blood vessels, are inconsistent in performance and have to be placed via invasive surgery. Other devices migrate out of position or require suture sewing or hooks / barbs to be held in place or are too rigid to maintain vessel wall pulsatility. Embodiments of the disclosure may help to avoid such problems.
[0165] In certain embodiments, the described system may include first and second power sources, e.g., batteries and control electronics for redundant uninterrupted operation of the pulsating intravascular device. The control and power source module may be configured to accommodate a variety of wearable configurations for patient convenience and comfort.
[0166] In certain embodiments, the descnbed system may be utilized with the device in a plurality of scalable power modes and / or coupling modes.
[0167] In certain embodiments, the described system may be utilized by measuring and calculating parameters to control and monitor pulsatile blood flow within the subject’s blood vessel(s). Accordingly, embodiments of the disclosure supplement pulsatile blood flow with minimization of hemolysis and blood clot formation and without eliminating pulsatile vessel wall movement.
[0168] In the Brief Summary and in the Detailed Description above, the claims below, and in the accompanying drawings, reference is made to particular features (including method acts) of the present disclosure. It is to be understood that the disclosure includes all possible combinations of such particular features. For example, where a particular feature is disclosed in the context of a particular embodiment, or a particular claim, that feature can also be used, to the extent possible, in combination with and / or in the context of other particular aspects and embodiments described herein.
[0169] As used herein, the term “configured” refers to a size, shape, material composition, material distribution, orientation, and arrangement of one or more of at least one structure and at least one apparatus facilitating operation of one or more of the structures and the apparatus in a predetermined way. As used herein, the terms “comprising” and “including,” and grammatical equivalents thereof include both open-ended terms that do not exclude additional, unrecited elements or method acts, and more restrictive terms such as “consisting of’ and “consisting essentially of’ and grammatical equivalents thereof.
[0170] As used herein, the term “about,” when used in reference to a numerical value for a particular parameter, is inclusive of the numerical value and a degree of variance from the numerical value that one of ordinary skill in the art would understand is within acceptable tolerances for the particular parameter. For example, “about,” in reference to a numerical value, may include additional numerical values within a range of from 90.0 percent to 110.0 percent of the numerical value, such as within a range of from 95.0 percent to 105.0 percent of the numerical value, within a range of from 97.5 percent to 102.5 percent of the numerical value, within a range of from 99.0 percent to 101.0 percent of the numerical value, within a range of from 99.5 percent to 100.5 percent of the numerical value, or within a range of from 99.9 percent to 100.1 percent of the numerical value.
[0171] As used herein, the term “substantially” in reference to a given parameter, property, or condition means and includes to a degree that one of ordinary skill in the art would understand that the given parameter, property, or condition is met with a degree of variance, such as within acceptable tolerances. By way of example, depending on the particular parameter, property, or condition that is substantially met, the parameter, property, or condition may be at least 90.0 percent met, at least 95.0 percent met, at least 99.0 percent met, at least 99.9 percent met, or even 100.0 percent met.
[0172] As used herein, the term “may” with respect to a material, structure, feature, function, or method act indicates that such is contemplated for use in implementation of an embodiment of the disclosure, and such term is used in preference to the more restrictive term “is” so as to avoid any implication that other compatible materials, structures, features, functions, and methods usable in combination therewith should or must be excluded.
[0173] As used herein, the terms “biocompatible material” and “biocompatible materials” refer to any materials suitable for being within a subject’s body. Biocompatible materials include ceramics and ceramic composites such as alumina (AI2O3), zirconia (ZrCh). hydroxyapatite (CaioiPO-iMOHji). and bioglass (e.g, composites including silica (S1O2). calcium (Ca), sodium oxide (Na2O), hydrogen (H), and / or phosphorous (P)). As non-limiting examples, bioglass may include 45S5 (e.g., 45% SiCh, 24.5% CaO, 24.5% Na2O, and 6% (P2O5)) and additional compositions described in Vidya Krishnan and T. Lakshmi, “Bioglass: A novel biocompatible innovation,” Journal of Advanced Pharmaceutical Technology & Research, Volume 4(2), Apr- Jun 2013, pages 78-83, DOI: 10.4103 / 2231-4040.111523. Biocompatible materials may additionally include metals and metal alloys, such as stainless steel, titanium and titanium alloys (e.g, Nitinol), cobalt-chromium alloys (e.g, ASTM F75). Furthermore, biocompatible material may include polymers, such as polyvinylchloride (PVC), polyethylene (PE), polypropylene (PP), polytetrafluoroethylene (PTFE), expanded PTFE (ePTFE), poly etheretherketone (“PEEK”), Poly-paraphenylene terephthalamide (K29) (e.g., Kevlar®), p-phenylene terephthalamide (PpPTA) (e g, Twaron®), polymethylmethacrylate (PMMA), trimethylcarbonate (C4H6O3), TMC NAD-lactide (CHafCeHsO^mfCrHeCEJnCHs), polylactic acid (PLA), and medical -grade silicone.
[0174] Although the present disclosure has been illustrated and described herein with reference to various embodiments and specific examples thereof, it will be readily apparent to those of ordinary skill in the art that other embodiments and examples may perform similar functions and / or achieve like results. All such embodiments and examples are within the spirit and scope of the present disclosure, are contemplated thereby, and are covered by the following claims and their legal equivalents.
[0175] REFERENCES
[0176] (the contents of each of which are incorporated herein by this reference)
[0177] Palma et al., “Pulsatile stent graft: a new alternative in chronic ventricular assistance,” Revista Brasileira de Cirurgia Cardiovascular (2013), 28(2):217; dx.doi.org / 10.5935 / 1678- 9741.20130031.
[0178] Vidya Krishnan and T. Lakshmi, “Bioglass: A novel biocompatible innovation,” Journal of Advanced Pharmaceutical Technology & Research, Volume 4(2), Apr- Jun 2013, pages 78-83, DOI: 10.4103 / 2231 -4040.1 1 1523.
[0179] Stephanie Wiesemann et al., “Impact of sequence type and field strength (1.5, 3, and 7T) on 4D flow MRI hemodynamic aortic parameters in healthy volunteers,” Magnetic Resonance in Medicine (Feb. 2021) Vo. 85, 721-733, doi: 10.1002 / mrm.28450. Epub 2020 Aug 4.
[0180] Alexander Kohn, “A New Approach to Electromagnetic Blood Flow Determining by Means of Catheter in an External Magnetic Field,” National Academy of Sciences Vol. 65, No. 3, pp. 521-527 (Mar. 1970) doi: 10.1073 / pnas.65.3.521.
[0181] Cubero et al., “Explonng the limits of magnetic field focusing: Simple planar geometries,” Results in Physics vol. 19 (Dec. 2020), doi.org / 10.1016 / j.rinp.2020.103562.
[0182] Britannica Online Encyclopedia, “ferroelectricity,” (Mar. 28, 2019), available: www.britannica.com / science / ferroelectricity (accessed May 13, 2022).
[0183] Britannica Online Encyclopedia, “ferromagnetism,” (Mar. 28, 2019), available: www.britannica.com / science / ferromagnetism (accessed May 13, 2022).
[0184] Jean Louis Van Belle, “Ferroelectrics and ferromagnetics,” Reading Feynman (Sep. 11, 2015), available: readingfeynman.org / 2015 / 09 / ll / ferroelectrics-and-ferromagnetics / (accessed May 13, 2022).
[0185] Christopher Wibbe, “A Comprehensive List of Ferromagnetic Materials” Moley Magnetics, Inc., available: www.moleymagneticsinc.com / a-comprehensive-list-of- ferromagnetic-materials / (accessed May 13, 2022).
[0186] Electrical4U, “Ferroelectric Materials: What Are They? (With Examples),” (Mar. 28, 2021) available: www.electrical4u.com / ferroelectric-materials / (accessed May 13, 2022).
[0187] Electrical4U, “Ferromagnetic Materials,” (Oct. 25, 2020) available: www.electrical4u.com / ferromagnetic-materials / (accessed May 13, 2022). HowStuffWorks, “How to Make a Magnet Stronger,” (Mar. 31, 2021), available totalelement.com / blogs / working-with-neodymium-magnets / will-stacking-magnets-together- make-them-stronger.
[0188] K&J Magnetics, Inc., “Doubled Forces,” available www.kjmagnetics.com / blog.asp?p=doubled-forces (accessed May 30, 2022).
[0189] Natalie A. Frey et al., “Magnetic nanoparticles: synthesis, functionalization, and applications in bioimaging and magnetic energy storage,” Chem. Soc. Rev. issue 9, pp. 3532- 2542 (Sep. 2009), doi:10.1039 / b815548h.
[0190] U.S. Patent 9,642,958 to Zilbershlag et al. (May 9, 2017) for “Coplanar Wireless Energy Transfer.”
[0191] Khan, Sadeque Reza et al. “Wireless Power Transfer Techniques for Implantable Medical Devices: A Review.” Sensors (Basel, Switzerland) vol. 20,12 3487, 19 Jun. 2020, doi: 10.3390 / s20123487.
[0192] U.S. Patent 9,308,303 to Badstilbner et al. (April 12, 2016) for “Transcutaneous power transmission and communication for implanted heart assist and other devices.”
[0193] U.S. Patent Publication 20140378742 to Badstilbner et al. (Dec. 25, 2014) for “Transcutaneous power transmission and communication for implanted heart assist and other devices.”
[0194] U.S. Patent 8,764,621 to Badstilbner et al. (July 1, 2014) for “Transcutaneous power transmission and communication for implanted heart assist and other devices.”
[0195] U.S. Patent Publication 20130289334 to Badstilbner et al. (Oct. 31, 2013) for “Transcutaneous power transmission and communication for implanted heart assist and other devices.”
[0196] U. S. Patent Publication No. 2021 / 0077687, titled “Circulatory Assist Pump,” to Leonhardt (Mar. 18, 2021).
[0197] PCT International Patent Publication WO2019183247A1, titled “Circulatory assist pump” to Leonhardt (Sept. 26, 2019).
[0198] US Patent Application Publication 2022 / 0117719 Al to Leonhardt (April 21, 2022) for “Pulsatile Vascular Stent Graft.”
Claims
CLAIMSWhat is claimed is:
1. A circulatory assist device comprising: an intravascular device comprising: a stent graft biased to expand radially outward such that at least a portion of an exterior surface of the stent graft is configured to contact an interior wall of a blood vessel of a subject so as to be retained in the blood vessel; and a band configured to change diameter in response to an applied magnetic field, the band comprising a non-polymeric ferromagnetic material which is contained within a biocompatible flexible material, which is therein configured to change a shape of the band in response to an applied magnetic field.
2. The circulatory assist device of claim 1, wherein the stent graft extends along an entire longitudinal length of the intravascular device, and the band comprises an annular or semi-annular band encompassing a section of the stent graft.
3. The circulatory assist device of claim 1 or 2, further comprising multiple bands, each band being configured to actuate separately along an axial length of the band in response to axial movement of an applied magnetic field.
4. The circulatory assist device of any one of claims 1 through 3, wherein the ferromagnetic material comprises ferromagnetic elements.
5. The circulatory assist device of any one of claims 1 through 4, wherein the band comprises additional material radially interposed between an interior quantity of the non- polymeric ferromagnetic material and an exterior quantity of the non-polymeric ferromagnetic material.
6. The circulatory assist device of claim 5, wherein the additional material comprises a biocompatible fluoropolymer, and wherein the non-polymeric ferromagnetic material comprises neodymium.
7. The circulatory assist device of any one of claims 1 through 7, wherein the non-polymeric ferromagnetic material of the band comprises non-polymeric ferromagnetic nanoparticles dispersed throughout the band.
8. A method of facilitating pulsatile blood flow in a blood vessel of a subject, the method comprising: positioning the circulatory assist device of any one of claims 1 - 7 within the blood vessel; and applying a magnetic field to the band of the intravascular device to change the shape of the portion of the intravascular device.
9. The method according to claim 8, wherein applying the magnetic field to the portion of the intravascular device comprises focusing the magnetic field at a plane perpendicular to an axial length of the intravascular device.
10. The method according to claim 9, wherein applying the magnetic field to the portion of the intravascular device comprises steering the focused magnetic field along the axial length of the portion of the intravascular device such that lengthwise sections of the portion of the intravascular device successively constrict to facilitate blood flow.
11. The method according to any one of claims 8 through 10, wherein applying the magnetic field to the portion of the intravascular device comprises applying a concentrated magnetic field through the skin, tissues, and the blood vessel of the subject to the non- polymeric ferromagnetic material of the portion of the intravascular device.
12. A circulatory assist device comprising: an intravascular device comprising: a stent graft biased to expand radially outward such that at least a portion of an exterior surface of the stent graft is configured to contact an interior wall of a blood vessel of a subject so as to be retained in the blood vessel, and a plurality of bands, each configured to change diameter in response to an applied magnetic field and comprising a ferromagnetic material; an electromagnet configured to generate the applied magnetic field; and a controller configured to modulate the electromagnet.
13. The circulatory assist device of claim 12, wherein the plurality of bands is arranged in series along an axial length of the intravascular device, each of the plurality of bands configured to independently change shape in response to a magnetic field applied thereto.
14. The circulatory assist device of claim 13, further comprising additional electromagnets arranged in series, each of the additional electromagnets configured to be independently activated and deactivated to selectively apply a magnetic field to change the diameter of a respective band of the plurality of bands.
15. The circulatory assist device of claim 14, further comprising a controller configured to independently activate the electromagnet and each of the electromagnets in series such that the respective band successively constricts or expands.
16. The circulatory assist device of any one of claims 12 through 15, wherein the intravascular device comprises alternating sections of the stent graft and the plurality of bands along an axial length of the intravascular device.
17. A circulatory assist device comprising: an intravascular device configured to contact an interior wall of a blood vessel of a subject so as to be retained in the blood vessel, a portion of the intravascular device comprising a ferromagnetic material configured to change diameter in response to an applied magnetic field, wherein the portion of the intravascular device comprises: a stent graft comprising a flexible material and a reinforcing structure; and a band comprising an additional flexible material and the ferromagnetic material, wherein the intravascular device comprises alternating sections of the stent graft and the band arranged around the circumference of the intravascular device, wherein the intravascular device exhibits a longitudinal length, and wherein the stent graft and the band each extend the longitudinal length of the intravascular device.
18. The circulatory assist device of claim 17, wherein the intravascular device comprises an inner member and an outer member.
19. The circulatory assist device of claim 18, wherein the inner member of the intravascular device comprises a stent graft and the band.
20. The circulatory assist device of claim 18 or claim 19, wherein the inner member comprises an electrically conductive element.
21. The circulatory assist device of claim 20, further comprising: an internal battery in electronic communication with the electrically conductive element; and electronics in electronic communication with the electrically conductive element and the internal battery.
22. The circulatory assist device of claim 21, wherein the electronics comprise: a wireless charging coil; an internal controller; and a sensor.
23. The circulatory assist device of any one of claims 17 through 21, further comprising an internal electromagnet positioned within the inner member of the intravascular device, the internal electromagnet configured to generate an internal magnetic field to actuate the band of the intravascular device.
24. The circulatory assist device of any one of claims 17 through 21, further comprising multiple internal electromagnets positioned w ithin the intravascular device, each of the internal electromagnets independently activatable.
25. A method of facilitating pulsatile blood flow in a blood vessel of a subject, the method comprising: inserting a circulatory assist device within the blood vessel of the subject, activating a first internal electromagnet, deactivating the first internal electromagnet, activating a second electromagnet, and deactivating the second electromagnet.
26. The method of claim 25, further comprising waiting for a duration of time in response to activating the first electromagnet.
Citation Information
Patent Citations
Dynamically adjustable gastric implants
US20070265646A1
System and method to counter material deposition on devices in the urinary tract
US20080208083A1
Vascular graft prosthesis with selective flow reduction
US20100318175A1
Wireless Resonant Circuit and Variable Inductance Vascular Monitoring Implants and Anchoring Structures Therefore
US20210196199A1
Pulsatile vascular stent graft
US20220117719A1
